Identifying Potential Biomarkers and Clinical Trial Outcomes for Future Clinical Trials for SLC13A5 Deficiency

dc.contributor.advisorSimecka, Jerry W.
dc.contributor.committeeMemberCihlar, Jennifer C.
dc.creatorCooper, Sydney
dc.date.accessioned2023-04-04T20:32:06Z
dc.date.available2023-04-04T20:32:06Z
dc.date.issued2022-12
dc.format.mimetypeapplication/pdf
dc.identifier.urihttps://hdl.handle.net/20.500.12503/32099
dc.language.isoen
dc.subjectSLC13A5 deficiency
dc.subjectgene therapy
dc.subjectrare disease
dc.subject.meshGenetic Therapy
dc.subject.meshRare Diseases
dc.subject.meshBiomarkers
dc.titleIdentifying Potential Biomarkers and Clinical Trial Outcomes for Future Clinical Trials for SLC13A5 Deficiency
dc.typeThesis
dc.type.materialtext
thesis.degree.departmentSchool of Biomedical Sciences
thesis.degree.disciplineClinical Research Management
thesis.degree.grantorUniversity of North Texas Health Science Center at Fort Worth
thesis.degree.nameMaster of Science

Files

Original bundle

Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
2022_12_sbs_Cooper_Sydney_practicum.pdf
Size:
346.37 KB
Format:
Adobe Portable Document Format
Description: